DENTSPLY SIRONA Inc. (NASDAQ:XRAY) is one of the stocks Jim Cramer offered insights on. Toward the end of the lightning round, responding to a caller’s question about the stock, Cramer commented: “You know, do you know that this used to be a very expensive growth company, and now it is worth very little? And I think it absolutely represents some value here. I’m glad you brought it to my attention. I’m going to suggest that you buy some and put it away.” Photo by Adam Nowakowski on Unsplash DENTSPLY SI ...

Core Insights - DENTSPLY SIRONA Inc. (NASDAQ:XRAY) is recognized for its significant upside potential and is included in the list of the 15 Best Robotics Stocks to Buy under $20 [1] Strategic Roadmap - At the Morgan Stanley 23rd Annual Global Healthcare Conference, DENTSPLY SIRONA's leadership presented a refined strategy roadmap focusing on decision-making speed, resource allocation to R&D and sales, and increasing U.S. market penetration ahead of future product launches [2][3] - The company aims for above 19% fiscal 2025 margins and $300–400 million in annual cash flow, with a target of $3 EPS for 2026, while forecasting a 2%–4% decline in organic revenue for 2025 and an annual tariff impact of $80 million [3] Operational Improvements - Management acknowledged challenges in implementing ERP but emphasized enhancing customer satisfaction, expanding direct distribution channels, and considering bolt-on acquisitions to increase the total addressable market [4] Business Segments - DENTSPLY SIRONA operates through four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare, providing cloud-enabled dental tools, supplies, and healthcare solutions globally [5]